Nano-antimicrobials: A new paradigm for combating mycobacterial resistance.
CONCLUSION: Nanomedicine holds bright prospect to perform key role in global tuberculosis elimination program.
PMID: 31218956 [PubMed - as supplied by publisher]
Source: Current Pharmaceutical Design - Category: Drugs & Pharmacology Authors: Minakshi P, Ghosh M, Brar B, Kumar R, Lambe UP, Ranjan K, Prasad G, Manoj J Tags: Curr Pharm Des Source Type: research
More News: Chemistry | Drugs & Pharmacology | Infectious Diseases | Multidrug Resistance | Nanotechnology | Superbugs | Tuberculosis | Vaccines | Veterinary Vaccinations